Bin Xu - Publications
Affiliations: | Chemistry | shanghai university, Shanghai, Shanghai Shi, China |
Year | Citation | Score | |||
---|---|---|---|---|---|
2016 | Zhang X, Ma S, Zhang R, Li S, Zhu D, Han D, Li X, Li C, Yan W, Sun D, Xu B, Wang Y, Cao F. Oncostatin M-induced cardiomyocyte dedifferentiation regulates the progression of diabetic cardiomyopathy through B-Raf/Mek/Erk signaling pathway. Acta Biochimica Et Biophysica Sinica. PMID 26837420 DOI: 10.1093/abbs/gmv137 | 0.332 | |||
2004 | Jacobson KA, Costanzi S, Ohno M, Joshi BV, Besada P, Xu B, Tchilibon S. Molecular recognition at purine and pyrimidine nucleotide (P2) receptors. Current Topics in Medicinal Chemistry. 4: 805-19. PMID 15078212 DOI: 10.2174/1568026043450961 | 0.631 | |||
2003 | Kim HS, Ohno M, Xu B, Kim HO, Choi Y, Ji XD, Maddileti S, Marquez VE, Harden TK, Jacobson KA. 2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists. Journal of Medicinal Chemistry. 46: 4974-87. PMID 14584948 DOI: 10.1021/Jm030127+ | 0.564 | |||
2002 | Xu B, Stephens A, Kirschenheuter G, Greslin AF, Cheng X, Sennelo J, Cattaneo M, Zighetti ML, Chen A, Kim SA, Kim HS, Bischofberger N, Cook G, Jacobson KA. Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation. Journal of Medicinal Chemistry. 45: 5694-709. PMID 12477353 DOI: 10.1021/Jm020173U | 0.559 | |||
Show low-probability matches. |